TradingView
RocketTickers
Jul 29, 2021 4:32 PM

Alnylam Reports Positive Topline Results from ILLUMINATE-C Phase Long

NASDAQ:ALNY60
Alnylam Pharmaceuticals, Inc.NASDAQ

Description

⋅
ALNY: Alnylam Pharmaceuticals, Inc.
2021-07-29 07:00:00
Alnylam Reports Positive Topline Results from ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1
Beyond Technical Analysis
More